Detailed Mechanism Funding and Narrative

Years of mechanism: 2016 2017 2018

Details for Mechanism ID: 18234
Country/Region: Malawi
Year: 2017
Main Partner: Right to Care
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: USAID
Total Funding: $8,064,878 Additional Pipeline Funding: $10,392,326

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: TB/HIV (HVTB) $403,244
Care: Pediatric Care and Support (PDCS) $241,946
Health Systems Strengthening (OHSS) $38,711
Prevention: HIV Testing and Counseling (HVCT) $806,488
Sexual Prevention: Other Sexual Prevention (HVOP) $203,235
Treatment: Adult Treatment (HTXS) $4,596,981
Treatment: Pediatric Treatment (PDTX) $1,774,273
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV_DSD 10-14, Female, Physical and/or Emotional Violence 2018 518
GEND_GBV_DSD 10-14, Female, Sexual Violence (Post-Rape Care) 2018 1,132
GEND_GBV_DSD 15-19, Female, Physical and/or Emotional Violence 2018 698
GEND_GBV_DSD 15-19, Female, Sexual Violence (Post-Rape Care) 2018 1,350
GEND_GBV_DSD 20-24, Female, Physical and/or Emotional Violence 2018 807
GEND_GBV_DSD 20-24, Female, Sexual Violence (Post-Rape Care) 2018 1,468
GEND_GBV_DSD By PEP service provision (related to sexual violence services provided) 2018 3,950
GEND_GBV_DSD By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2018 2,023
GEND_GBV_DSD By type of service: Sexual Violence (Post-Rape Care) 2018 3,950
GEND_GBV_DSD Number of people receiving post-GBV care 2018 5,973
HTC_TST_DSD By Test Result: Positive 2018 87,744
HTC_TST_DSD Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2018 1,485,426
HTC_TST_DSD Service Delivery Point (Facility) ANC: 10-14, Negative 2018 863
HTC_TST_DSD Service Delivery Point (Facility) ANC: 15-19, Negative 2018 56,587
HTC_TST_DSD Service Delivery Point (Facility) ANC: 15-19, Positive 2018 1,046
HTC_TST_DSD Service Delivery Point (Facility) ANC: 20-24, Negative 2018 86,113
HTC_TST_DSD Service Delivery Point (Facility) ANC: 20-24, Positive 2018 2,917
HTC_TST_DSD Service Delivery Point (Facility) ANC: 25-49, Negative 2018 113,393
HTC_TST_DSD Service Delivery Point (Facility) ANC: 25-49, Positive 2018 6,451
HTC_TST_DSD Service Delivery Point (Facility) ANC: 50+, Negative 2018 560
HTC_TST_DSD Service Delivery Point (Facility) Index: 1-9, Negative 2018 45,067
HTC_TST_DSD Service Delivery Point (Facility) Index: 1-9, Positive 2018 3,108
HTC_TST_DSD Service Delivery Point (Facility) Index: 10-14, Female, Negative 2018 9,804
HTC_TST_DSD Service Delivery Point (Facility) Index: 10-14, Female, Positive 2018 677
HTC_TST_DSD Service Delivery Point (Facility) Index: 10-14, Male, Negative 2018 9,516
HTC_TST_DSD Service Delivery Point (Facility) Index: 10-14, Male, Positive 2018 657
HTC_TST_DSD Service Delivery Point (Facility) Index: 15-19, Female, Negative 2018 14,642
HTC_TST_DSD Service Delivery Point (Facility) Index: 15-19, Female, Positive 2018 1,115
HTC_TST_DSD Service Delivery Point (Facility) Index: 15-19, Male, Negative 2018 17,714
HTC_TST_DSD Service Delivery Point (Facility) Index: 15-19, Male, Positive 2018 1,335
HTC_TST_DSD Service Delivery Point (Facility) Index: 20-24, Female, Negative 2018 14,642
HTC_TST_DSD Service Delivery Point (Facility) Index: 20-24, Female, Positive 2018 1,115
HTC_TST_DSD Service Delivery Point (Facility) Index: 20-24, Male, Negative 2018 17,714
HTC_TST_DSD Service Delivery Point (Facility) Index: 20-24, Male, Positive 2018 1,335
HTC_TST_DSD Service Delivery Point (Facility) Index: 25-49, Female, Negative 2018 42,961
HTC_TST_DSD Service Delivery Point (Facility) Index: 25-49, Female, Positive 2018 3,304
HTC_TST_DSD Service Delivery Point (Facility) Index: 25-49, Male, Negative 2018 113,909
HTC_TST_DSD Service Delivery Point (Facility) Index: 25-49, Male, Positive 2018 8,451
HTC_TST_DSD Service Delivery Point (Facility) Index: 50+, Female, Negative 2018 425
HTC_TST_DSD Service Delivery Point (Facility) Index: 50+, Female, Positive 2018 16
HTC_TST_DSD Service Delivery Point (Facility) Index: <1, Negative 2018 5,640
HTC_TST_DSD Service Delivery Point (Facility) Index: <1, Positive 2018 375
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 1-9, Negative 2018 27,082
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 1-9, Positive 2018 2,027
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 10-14, Female, Negative 2018 5,902
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 10-14, Female, Positive 2018 426
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 10-14, Male, Negative 2018 5,709
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 10-14, Male, Positive 2018 420
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 15-19, Female, Negative 2018 2,427
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 15-19, Female, Positive 2018 147
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 15-19, Male, Negative 2018 3,817
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 15-19, Male, Positive 2018 264
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 20-24, Female, Negative 2018 2,427
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 20-24, Female, Positive 2018 147
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 20-24, Male, Negative 2018 3,817
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 20-24, Male, Positive 2018 264
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 25-49, Female, Negative 2018 5,290
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 25-49, Female, Positive 2018 350
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 25-49, Male, Negative 2018 13,886
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 25-49, Male, Positive 2018 977
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 50+, Female, Negative 2018 26
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 50+, Male, Negative 2018 719
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 50+, Male, Positive 2018 23
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: <1, Negative 2018 3,399
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: <1, Positive 2018 239
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 1-9, Negative 2018 2,973
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 1-9, Positive 2018 189
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 10-14, Female, Negative 2018 645
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 10-14, Female, Positive 2018 17
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 10-14, Male, Negative 2018 624
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 10-14, Male, Positive 2018 17
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 15-19, Female, Negative 2018 3,176
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 15-19, Female, Positive 2018 197
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 15-19, Male, Negative 2018 16,273
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 15-19, Male, Positive 2018 1,075
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 20-24, Female, Negative 2018 3,176
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 20-24, Female, Positive 2018 197
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 20-24, Male, Negative 2018 16,273
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 20-24, Male, Positive 2018 1,075
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 25-49, Female, Negative 2018 5,926
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 25-49, Female, Positive 2018 348
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 25-49, Male, Negative 2018 28,498
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 25-49, Male, Positive 2018 1,885
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 50+, Female, Negative 2018 27
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 50+, Male, Negative 2018 1,486
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 50+, Male, Positive 2018 65
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: <1, Positive 2018 5
HTC_TST_DSD Service Delivery Point (Facility) TB: 1-9, Negative 2018 1,847
HTC_TST_DSD Service Delivery Point (Facility) TB: 1-9, Positive 2018 143
HTC_TST_DSD Service Delivery Point (Facility) TB: 10-14, Female, Negative 2018 396
HTC_TST_DSD Service Delivery Point (Facility) TB: 10-14, Female, Positive 2018 10
HTC_TST_DSD Service Delivery Point (Facility) TB: 10-14, Male, Negative 2018 386
HTC_TST_DSD Service Delivery Point (Facility) TB: 10-14, Male, Positive 2018 9
HTC_TST_DSD Service Delivery Point (Facility) TB: 15-19, Female, Negative 2018 1,671
HTC_TST_DSD Service Delivery Point (Facility) TB: 15-19, Female, Positive 2018 121
HTC_TST_DSD Service Delivery Point (Facility) TB: 15-19, Male, Negative 2018 5,869
HTC_TST_DSD Service Delivery Point (Facility) TB: 15-19, Male, Positive 2018 449
HTC_TST_DSD Service Delivery Point (Facility) TB: 20-24, Female, Negative 2018 1,671
HTC_TST_DSD Service Delivery Point (Facility) TB: 20-24, Female, Positive 2018 121
HTC_TST_DSD Service Delivery Point (Facility) TB: 20-24, Male, Negative 2018 5,869
HTC_TST_DSD Service Delivery Point (Facility) TB: 20-24, Male, Positive 2018 449
HTC_TST_DSD Service Delivery Point (Facility) TB: 25-49, Female, Negative 2018 5,105
HTC_TST_DSD Service Delivery Point (Facility) TB: 25-49, Female, Positive 2018 377
HTC_TST_DSD Service Delivery Point (Facility) TB: 25-49, Male, Negative 2018 27,454
HTC_TST_DSD Service Delivery Point (Facility) TB: 25-49, Male, Positive 2018 2,154
HTC_TST_DSD Service Delivery Point (Facility) TB: 50+, Female, Negative 2018 31
HTC_TST_DSD Service Delivery Point (Facility) TB: 50+, Male, Negative 2018 1,429
HTC_TST_DSD Service Delivery Point (Facility) TB: 50+, Male, Positive 2018 97
HTC_TST_DSD Service Delivery Point (Facility) TB: <1, Negative 2018 222
HTC_TST_DSD Service Delivery Point (Facility) TB: <1, Positive 2018 3
HTC_TST_DSD Service Delivery Point (Facility) VCT: 1-9, Negative 2018 3,409
HTC_TST_DSD Service Delivery Point (Facility) VCT: 1-9, Positive 2018 226
HTC_TST_DSD Service Delivery Point (Facility) VCT: 10-14, Female, Negative 2018 740
HTC_TST_DSD Service Delivery Point (Facility) VCT: 10-14, Female, Positive 2018 23
HTC_TST_DSD Service Delivery Point (Facility) VCT: 10-14, Male, Negative 2018 723
HTC_TST_DSD Service Delivery Point (Facility) VCT: 10-14, Male, Positive 2018 23
HTC_TST_DSD Service Delivery Point (Facility) VCT: 15-19, Female, Negative 2018 45,303
HTC_TST_DSD Service Delivery Point (Facility) VCT: 15-19, Female, Positive 2018 2,866
HTC_TST_DSD Service Delivery Point (Facility) VCT: 15-19, Male, Negative 2018 78,656
HTC_TST_DSD Service Delivery Point (Facility) VCT: 15-19, Male, Positive 2018 5,097
HTC_TST_DSD Service Delivery Point (Facility) VCT: 20-24, Female, Negative 2018 45,303
HTC_TST_DSD Service Delivery Point (Facility) VCT: 20-24, Female, Positive 2018 2,866
HTC_TST_DSD Service Delivery Point (Facility) VCT: 20-24, Male, Negative 2018 78,656
HTC_TST_DSD Service Delivery Point (Facility) VCT: 20-24, Male, Positive 2018 5,097
HTC_TST_DSD Service Delivery Point (Facility) VCT: 25-49, Female, Negative 2018 83,846
HTC_TST_DSD Service Delivery Point (Facility) VCT: 25-49, Female, Positive 2018 4,984
HTC_TST_DSD Service Delivery Point (Facility) VCT: 25-49, Male, Negative 2018 271,704
HTC_TST_DSD Service Delivery Point (Facility) VCT: 25-49, Male, Positive 2018 17,747
HTC_TST_DSD Service Delivery Point (Facility) VCT: 50+, Female, Negative 2018 854
HTC_TST_DSD Service Delivery Point (Facility) VCT: 50+, Female, Positive 2018 23
HTC_TST_DSD Service Delivery Point (Facility) VCT: 50+, Male, Negative 2018 14,287
HTC_TST_DSD Service Delivery Point (Facility) VCT: 50+, Male, Positive 2018 929
HTC_TST_DSD Service Delivery Point (Facility) VCT: <1, Negative 2018 423
HTC_TST_DSD Service Delivery Point (Facility) VCT: <1, Positive 2018 6
HTC_TST_DSD Service Delivery Point (Facility) VMMC: 15-19, Negative 2018 970
HTC_TST_DSD Service Delivery Point (Facility) VMMC: 15-19, Positive 2018 3
HTC_TST_DSD Service Delivery Point (Facility) VMMC: 20-24, Negative 2018 970
HTC_TST_DSD Service Delivery Point (Facility) VMMC: 20-24, Positive 2018 3
HTC_TST_DSD Service Delivery Point (Facility) VMMC: 25-49, Negative 2018 10,283
HTC_TST_DSD Service Delivery Point (Facility) VMMC: 25-49, Positive 2018 120
HTC_TST_DSD Service Delivery Point (Facility) VMMC: 50+, Negative 2018 531
HTC_TST_DSD Service Delivery Point (Facility) VMMC: 50+, Positive 2018 1
HTC_TST_DSD Service Delivery Point (Facility)Other PITC: <1, Negative 2018 367
HTC_TST_DSD Service Delivery Point by Agg Age (Community) Index Mod: 15+, Female, Negative 2018 2,365
HTC_TST_DSD Service Delivery Point by Agg Age (Community) Index Mod: 15+, Female, Positive 2018 178
HTC_TST_DSD Service Delivery Point by Agg Age (Community) Index Mod: 15+, Male, Negative 2018 4,180
HTC_TST_DSD Service Delivery Point by Agg Age (Community) Index Mod: 15+, Male, Positive 2018 330
HTC_TST_DSD Sum of Test Result disaggregates 2018 87,744
PMTCT_ART_DSD Already on ART at beginning of current pregnancy 2018 12,280
PMTCT_ART_DSD New on ART 2018 11,102
PMTCT_ART_DSD Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2018 23,382
PMTCT_ART_DSD Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 288,648
PMTCT_EID_DSD Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2018 23,389
PMTCT_EID_DSD Number of infants with a negative virological test result between 2 and 12 months of birth 2018 15,352
PMTCT_EID_DSD Number of infants with a negative virological test result within 2 months of birth 2018 7,546
PMTCT_EID_DSD Number of infants with a positive virological test result between 2 and 12 months of birth 2018 306
PMTCT_EID_DSD Number of infants with a positive virological test result within 2 months of birth 2018 185
PMTCT_STAT_DSD By Age (Denominator): 10-14 2018 907
PMTCT_STAT_DSD By Age (Denominator): 20-24 2018 100,267
PMTCT_STAT_DSD By Age (Denominator): 25-49 2018 138,246
PMTCT_STAT_DSD By Age (Denominator): 50+ 2018 610
PMTCT_STAT_DSD By Age (Denominator): <15-19 2018 63,812
PMTCT_STAT_DSD By Age (Numerator): 10-14 2018 863
PMTCT_STAT_DSD By Age (Numerator): 15-19 2018 60,623
PMTCT_STAT_DSD By Age (Numerator): 20-24 2018 95,255
PMTCT_STAT_DSD By Age (Numerator): 25-49 2018 131,330
PMTCT_STAT_DSD By Age (Numerator): 50+ 2018 577
PMTCT_STAT_DSD By Number of known positives: 15-19 2018 1,296
PMTCT_STAT_DSD By Number of known positives: 20-24 2018 3,632
PMTCT_STAT_DSD By Number of known positives: 25-49 2018 8,038
PMTCT_STAT_DSD By Number of new negative: 10-14 2018 863
PMTCT_STAT_DSD By Number of new negative: 15-19 2018 58,222
PMTCT_STAT_DSD By Number of new negative: 20-24 2018 88,541
PMTCT_STAT_DSD By Number of new negative: 25-49 2018 116,468
PMTCT_STAT_DSD By Number of new negative: 50+ 2018 577
PMTCT_STAT_DSD By Number of new positives: 15-19 2018 1,106
PMTCT_STAT_DSD By Number of new positives: 20-24 2018 3,084
PMTCT_STAT_DSD By Number of new positives: 25-49 2018 6,821
PMTCT_STAT_DSD Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 288,648
TB_ART_DSD Aggregated Age/Sex: Female 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 189
TB_ART_DSD Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 182
TB_ART_DSD Aggregated Age/Sex: Female <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 200
TB_ART_DSD Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 193
TB_ART_DSD Aggregated Age/Sex: Male 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 1,145
TB_ART_DSD Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 1,109
TB_ART_DSD Aggregated Age/Sex: Male <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 2,573
TB_ART_DSD Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 2,484
TB_ART_DSD The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2018 4,108
TB_ART_DSD The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2018 3,969
TB_PREV_DSD By Age/Sex (Denominator): 15+, Female 2018 79,889
TB_PREV_DSD By Age/Sex (Denominator): 15+, Male 2018 44,628
TB_PREV_DSD By Age/Sex (Denominator): <15, Female 2018 6,766
TB_PREV_DSD By Age/Sex (Denominator): <15, Male 2018 6,496
TB_PREV_DSD By Age/Sex (Numerator): 15+, Female 2018 77,496
TB_PREV_DSD By Age/Sex (Numerator): 15+, Male 2018 43,307
TB_PREV_DSD By Age/Sex (Numerator): <15, Female 2018 6,565
TB_PREV_DSD By Age/Sex (Numerator): <15, Male 2018 6,305
TB_PREV_DSD By Therapy type (Denominator): Continuous IPT 2018 137,779
TB_PREV_DSD By Therapy type (Numerator): Continuous IPT 2018 133,673
TB_PREV_DSD The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period 2018 133,673
TB_PREV_DSD The number of ART patients who were newly started on TB preventive therapy (including those who newly started on TB preventive therapy in this reporting period and those who started in the previous reporting period but had not been reported as they did not fulfill the minimum requirements for the previous reporting period) 2018 137,779
TB_STAT_DSD Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 2,476
TB_STAT_DSD Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 2,359
TB_STAT_DSD Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 440
TB_STAT_DSD Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 421
TB_STAT_DSD Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 5,170
TB_STAT_DSD Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 4,940
TB_STAT_DSD Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 441
TB_STAT_DSD Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 421
TB_STAT_DSD Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2018 8,142
TB_STAT_DSD Total number of registered new and relapsed TB cases, during the reporting period 2018 8,541
TX_CURR_DSD Age/Sex: 10-14 Female 2018 3,536
TX_CURR_DSD Age/Sex: 10-14 Male 2018 3,432
TX_CURR_DSD Age/Sex: 15-19 Female 2018 10,743
TX_CURR_DSD Age/Sex: 15-19 Male 2018 6,522
TX_CURR_DSD Age/Sex: 20-24 Female 2018 14,617
TX_CURR_DSD Age/Sex: 20-24 Male 2018 6,522
TX_CURR_DSD Age/Sex: 25-49 Female 2018 189,220
TX_CURR_DSD Age/Sex: 25-49 Male 2018 121,317
TX_CURR_DSD Age/Sex: 50+ Female 2018 1,087
TX_CURR_DSD Age/Sex: 50+ Male 2018 6,390
TX_CURR_DSD Age/Sex: <1 2018 5,713
TX_CURR_DSD Age/Sex: <1-9 2018 24,402
TX_CURR_DSD Number of adults and children receiving antiretroviral therapy (ART) 2018 393,501
TX_CURR_DSD Sum of age/sex disaggregates 2018 17,265
TX_NEW_DSD Breastfeeding status 2018 5,336
TX_NEW_DSD By Age/Sex: 1-9 2018 6,437
TX_NEW_DSD By Age/Sex: 10-14 Female 2018 899
TX_NEW_DSD By Age/Sex: 10-14 Male 2018 815
TX_NEW_DSD By Age/Sex: 15-19 Female 2018 6,485
TX_NEW_DSD By Age/Sex: 15-19 Male 2018 11,277
TX_NEW_DSD By Age/Sex: 20-24 Female 2018 8,769
TX_NEW_DSD By Age/Sex: 20-24 Male 2018 11,277
TX_NEW_DSD By Age/Sex: 25-49 Female 2018 13,930
TX_NEW_DSD By Age/Sex: 25-49 Male 2018 30,989
TX_NEW_DSD By Age/Sex: 50+ Female 2018 70
TX_NEW_DSD By Age/Sex: 50+ Male 2018 1,630
TX_NEW_DSD By Age/Sex: <1 2018 470
TX_NEW_DSD Number of adults and children newly enrolled on antiretroviral therapy (ART) 2018 93,020
TX_NEW_DSD Pregnancy status 2018 19,701
TX_NEW_DSD Sum of Age/Sex disaggregates 2018 86,141
TX_PVLS_DSD Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 126,757
TX_PVLS_DSD Denominator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2018 3,809
TX_PVLS_DSD Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 68,585
TX_PVLS_DSD Denominator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2018 2,099
TX_PVLS_DSD Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 6,432
TX_PVLS_DSD Denominator: Aggregate Age/Sex by Indication: <15 Female Targeted 2018 169
TX_PVLS_DSD Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 6,433
TX_PVLS_DSD Denominator: Aggregate Age/Sex by Indication: <15 Male Targeted 2018 169
TX_PVLS_DSD Denominator: Indication: Routine 2018 208,207
TX_PVLS_DSD Denominator: Indication: Targeted 2018 6,246
TX_PVLS_DSD Denominator: Preg/BF by Indication: Breastfeeding Routine 2018 26,393
TX_PVLS_DSD Denominator: Preg/BF by Indication: Breastfeeding Targeted 2018 774
TX_PVLS_DSD Denominator: Preg/BF by Indication: Pregnant Routine 2018 26,393
TX_PVLS_DSD Denominator: Preg/BF by Indication: Pregnant Targeted 2018 774
TX_PVLS_DSD Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2018 214,453
TX_PVLS_DSD Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2018 193,003
TX_PVLS_DSD Numerator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 114,086
TX_PVLS_DSD Numerator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2018 3,413
TX_PVLS_DSD Numerator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 61,713
TX_PVLS_DSD Numerator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2018 1,913
TX_PVLS_DSD Numerator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 5,790
TX_PVLS_DSD Numerator: Aggregate Age/Sex by Indication: <15 Female Targeted 2018 149
TX_PVLS_DSD Numerator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 5,790
TX_PVLS_DSD Numerator: Aggregate Age/Sex by Indication: <15 Male Targeted 2018 148
TX_PVLS_DSD Numerator: Indication: Routine 2018 187,381
TX_PVLS_DSD Numerator: Indication: Targeted 2018 5,622
TX_PVLS_DSD Numerator: Preg/BF by Indication: Breastfeeding Routine 2018 23,748
TX_PVLS_DSD Numerator: Preg/BF by Indication: Breastfeeding Targeted 2018 698
TX_PVLS_DSD Numerator: Preg/BF by Indication: Pregnant Routine 2018 23,748
TX_PVLS_DSD Numerator: Preg/BF by Indication: Pregnant Targeted 2018 698
TX_RET_DSD Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 51,442
TX_RET_DSD Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 39,068
TX_RET_DSD Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 26,154
TX_RET_DSD Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 19,758
TX_RET_DSD Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 3,503
TX_RET_DSD Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 2,317
TX_RET_DSD Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 3,503
TX_RET_DSD Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 2,317
TX_RET_DSD Denominator by Status: Breastfeeding 2018 2,360
TX_RET_DSD Denominator by Status: Pregnant 2018 1,267
TX_RET_DSD Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2018 63,461
TX_RET_DSD Numerator by Status: Breastfeeding 2018 1,894
TX_RET_DSD Numerator by Status: Pregnant 2018 1,021
TX_RET_DSD Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2018 84,603
TX_TB_DSD Denominator: By Aggregated Age/Sex: <15, Female 2018 18,030
TX_TB_DSD Denominator: By Aggregated Age/Sex: <15, Male 2018 18,031
TX_TB_DSD Denominator: By Aggregated Age/Sex:15+, Female 2018 203,372
TX_TB_DSD Denominator: By Aggregated Age/Sex:15+, Male 2018 112,204
TX_TB_DSD Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Gene Xpert MTB / R if Assay 2018 2,722
TX_TB_DSD Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Other (No Xpert) 2018 108
TX_TB_DSD Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Smear Only 2018 10,805
TX_TB_DSD Denominator: By Screen Result: Negative 2018 329,879
TX_TB_DSD Denominator: By Screen Result: Positive 2018 13,435
TX_TB_DSD Denominator: Number of ART patients who had a specimen sent for bacteriologic diagnosis of active TB disease 2018 13,397
TX_TB_DSD Number of ART patients who were screened for TB at least once during the reporting period 2018 351,637
TX_TB_DSD Number of ART patients who were started on TB treatment during the reporting period 2018 3,588
TX_TB_DSD Numerator: By Aggregated Age/Sex: 15+, Female 2018 2,119
TX_TB_DSD Numerator: By Aggregated Age/Sex: 15+, Male 2018 1,149
TX_TB_DSD Numerator: By Aggregated Age/Sex: <15, Female 2018 159
TX_TB_DSD Numerator: By Aggregated Age/Sex: <15, Male 2018 161
Cross Cutting Budget Categories and Known Amounts Total: $2,648,000
Gender: Gender Based Violence (GBV) $500,000
GBV Prevention
Implementation
Capacity building
Human Resources for Health $525,000
Construction $140,000
Motor Vehicles: Purchased $703,000
Water $100,000
Food and Nutrition: Policy, Tools, and Service Delivery $100,000
Renovation $580,000